Latest Financials News

Globe International Limited reported a decline in revenue and profit for FY25, reflecting a strategic shift away from non-core brands. Despite this, the company maintains strong profitability in Australia and a solid cash position, while declaring a fully franked dividend of 20 cents per share.

Symal Group is set to acquire Locale Civil for up to $35 million, securing a $230 million civil works contract and enhancing its earnings from the first year. This move strategically expands Symal’s footprint in Australia’s utilities infrastructure sector.

Aerometrex has confirmed Robert Veitch as its new CEO and Managing Director, following a strategic overhaul that delivered $2 million in annual cost savings and boosted its MetroMap revenue stream.

Trading in Aspermont Limited shares has resumed following the ASX's immediate lifting of the suspension after the company released a key announcement.

Aspermont launches its new Mining-IQ data platform, partners with Rio Tinto to digitize historic mining archives using AI, and raises A$1.75 million from European investors to fuel growth.

Desane Group Holdings anticipates a strong leap in earnings before interest and tax for FY25, nearly doubling last year’s figure. The final audited results are expected by the end of August.

MIXI Australia has extended its unconditional all-cash takeover offer for PointsBet shares, providing shareholders with a certain and attractive alternative to PointsBet’s conditional scrip bid. The offer now runs until 29 August 2025 at A$1.30 per share for acquisitions above 90%.

Melbana Energy is set to commence drilling the Amistad-2 well in Cuba, aiming to boost production and prepare for its first crude export later this year.

Ausgold Limited has resolved a long-standing legal dispute by acquiring critical freehold land for its Katanning Gold Project, unlocking new drilling opportunities and prompting a re-optimisation of its feasibility study.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Melbana Energy has successfully raised $7 million through a discounted share placement with attaching and bonus options, aiming to finance drilling at its Amistad-2 well and support general corporate needs.